Published in J Med Case Rep on May 19, 2014
Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS. Neurol Neuroimmunol Neuroinflamm (2017) 0.75
Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med (2005) 10.39
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation (2012) 3.12
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol (2006) 2.80
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol (2008) 2.58
Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol (2012) 2.12
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol (2013) 1.79
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology (2008) 1.72
Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch Neurol (2011) 1.61
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler (2007) 1.45
Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy. JAMA Neurol (2013) 1.30
Does natalizumab therapy worsen neuromyelitis optica? Neurology (2012) 1.19
Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Mult Scler (2011) 1.19
Natalizumab and the development of extensive brain lesions in neuromyelitis optica. J Neurol (2013) 0.89
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients. Arch Neurol (2012) 0.83
Is it too early to predict the failure of natalizumab in NMO? Arch Neurol (2012) 0.79
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol (2007) 6.15
Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke (2009) 5.28
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest (2005) 3.22
Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke (2007) 2.56
Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke (2007) 2.54
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36
Genome of Herbaspirillum seropedicae strain SmR1, a specialized diazotrophic endophyte of tropical grasses. PLoS Genet (2011) 1.91
Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? Stroke (2003) 1.90
Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol (2011) 1.83
Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke (2002) 1.73
TRPA1 and TRPM8 activation in humans: effects of cinnamaldehyde and menthol. Neuroreport (2005) 1.72
Sensory signs in complex regional pain syndrome and peripheral nerve injury. Pain (2011) 1.70
Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke (2009) 1.61
Differential recovery of behavioral status and brain function assessed with functional magnetic resonance imaging after mild traumatic brain injury in the rat. Crit Care Med (2007) 1.56
Posterior reversible encephalopathy syndrome. J Intensive Care Med (2011) 1.55
Therapy of acute basilar artery occlusion: intraarterial thrombolysis alone vs bridging therapy. Stroke (2008) 1.52
Weight approximation in stroke before thrombolysis: the WAIST-Study: a prospective observational "dose-finding" study. Stroke (2010) 1.48
Intraosseous hemangioma of the skull with dural tail sign: radiologic features with pathologic correlation. AJNR Am J Neuroradiol (2005) 1.46
Repetitive transcranial magnetic stimulation influences mood in healthy male volunteers. J Psychiatr Res (2011) 1.46
Retracted Changes of radial diffusivity and fractional anisotropy in the optic nerve and optic radiation of glaucoma patients. ScientificWorldJournal (2012) 1.46
Dose effect of intraventricular fibrinolysis in ventricular hemorrhage. Stroke (2011) 1.45
Comparison of ABC/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhage. Stroke (2005) 1.41
Cerebral salt-wasting syndrome in a patient with neuroleptic malignant syndrome. Arch Neurol (2007) 1.40
Images in neurology. Liposuction in mind. Arch Neurol (2009) 1.39
CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain (2009) 1.33
Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? J Neurochem (2004) 1.24
T-cell response against varicella-zoster virus in fingolimod-treated MS patients. Neurology (2013) 1.22
Complete genome sequence of the sugarcane nitrogen-fixing endophyte Gluconacetobacter diazotrophicus Pal5. BMC Genomics (2009) 1.22
The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease. Stem Cells (2007) 1.21
Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke (2002) 1.20
HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood (2007) 1.19
AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke (2010) 1.19
Functional connectivity of the human insular cortex during noxious and innocuous thermal stimulation. Neuroimage (2010) 1.16
EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. Int J Stroke (2014) 1.13
Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke (2005) 1.13
Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab (2003) 1.13
Efficient drug-delivery using magnetic nanoparticles--biodistribution and therapeutic effects in tumour bearing rabbits. Nanomedicine (2013) 1.12
Recanalization after endovascular treatment of intracerebral aneurysms. Neuroradiology (2006) 1.12
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS One (2011) 1.10
The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J Neurointerv Surg (2010) 1.08
High NIHSS values predict impairment of cardiovascular autonomic control. Stroke (2011) 1.05
Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke (2010) 1.05
Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke (2002) 1.04
Differential endogenous pain modulation in complex-regional pain syndrome. Brain (2009) 1.04
In vivo micro-CT imaging of rat brain glioma: a comparison with 3T MRI and histology. Neurosci Lett (2009) 1.02
Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patients. PLoS One (2011) 1.02
Antiedema therapy in ischemic stroke. Stroke (2007) 1.02
Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging. Stroke (2007) 1.02
Hyperbaric oxygen induces rapid protection against focal cerebral ischemia. Brain Res (2005) 1.02
Mechanisms of neuropathic pain. Eur Neuropsychopharmacol (2011) 1.02
Functional and structural imaging of pain-induced neuroplasticity. Curr Opin Anaesthesiol (2011) 1.01
The proteome of human brain microdialysate. Proteome Sci (2003) 1.01
Neuroprotection by hyperbaric oxygenation after experimental focal cerebral ischemia monitored by MRI. Stroke (2004) 1.01
Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol (2009) 1.01
Effects of natalizumab treatment on Foxp3+ T regulatory cells. PLoS One (2008) 1.01
Endovascular treatment of unruptured intracranial aneurysms: occurrence of thromboembolic events. Neurosurgery (2006) 1.00
Medial prefrontal cortex activity is predictive for hyperalgesia and pharmacological antihyperalgesia. J Neurosci (2009) 1.00
Analysis of the accuracy of high-resolution computed tomography techniques for the measurement of stapes prostheses. Eur Radiol (2009) 1.00
Avoiding in hospital delays and eliminating the three-hour effect in thrombolysis for stroke. Int J Stroke (2011) 1.00
Regional distribution of the prostaglandin E2 receptor EP1 in the rat brain: accumulation in Purkinje cells of the cerebellum. J Mol Neurosci (2005) 0.99
The hyperintense acute reperfusion marker on fluid-attenuated inversion recovery magnetic resonance imaging is caused by gadolinium in the cerebrospinal fluid. Stroke (2011) 0.98
Natural course of perihemorrhagic edema after intracerebral hemorrhage. Stroke (2011) 0.98
Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E? Semin Cancer Biol (2007) 0.98
Cerebral blood volume imaging by flat detector computed tomography in comparison to conventional multislice perfusion CT. Eur Radiol (2010) 0.98
Different degrees of hypothermia after experimental stroke: short- and long-term outcome. Stroke (2007) 0.98
An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol (2006) 0.98
Representation of cold allodynia in the human brain--a functional MRI study. Neuroimage (2007) 0.98
Diffusion tensor imaging detects rarefaction of optic radiation in glaucoma patients. Acad Radiol (2011) 0.97
Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Exp Neurol (2004) 0.97
Effects of induced hypertension on intracranial pressure and flow velocities of the middle cerebral arteries in patients with large hemispheric stroke. Stroke (2002) 0.97
Cortical activity associated with auditory hallucinations. Neuroreport (2004) 0.96
Brain activity during sympathetic response in anticipation and experience of pain. Hum Brain Mapp (2012) 0.96
Lumbar catheter for monitoring of intracranial pressure in patients with post-hemorrhagic communicating hydrocephalus. Neurocrit Care (2011) 0.96
Penumbra Stroke System as an "add-on" for the treatment of large vessel occlusive disease following thrombolysis: first results. Eur Radiol (2009) 0.96
Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia. Brain Res (2008) 0.96
Impaired spatial learning in a novel rat model of mild cerebral concussion injury. Exp Neurol (2005) 0.96
Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res Rev (2007) 0.95
Incidence and predictors of post-stroke epilepsy. Acta Neurol Scand (2013) 0.95
Visualisation of tumour regression after local chemotherapy with magnetic nanoparticles - a pilot study. Anticancer Res (2010) 0.94
Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution. Stroke (2011) 0.94
Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells. J Neurochem (2005) 0.94
Transient decrease in circulating dendritic cell precursors after acute stroke: potential recruitment into the brain. Clin Sci (Lond) (2009) 0.94
Hemicraniectomy for malignant middle cerebral artery infarction: retrospective consent to decompressive surgery depends on functional long-term outcome. Neurocrit Care (2010) 0.93
Lumbar drainage for communicating hydrocephalus after ICH with ventricular hemorrhage. Neurocrit Care (2006) 0.93
Impaired hand size estimation in CRPS. J Pain (2011) 0.93
Mild prolonged hypothermia for large intracerebral hemorrhage. Neurocrit Care (2013) 0.92
Long-term outcome after spontaneous cerebellar haemorrhage. Eur Neurol (2004) 0.92
Hypothermia for Stroke: call to action 2010. Int J Stroke (2010) 0.92
Enzyme replacement therapy improves cardiovascular responses to orthostatic challenge in Fabry patients. J Hypertens (2010) 0.91
A new model of thromboembolic stroke in the posterior circulation of the rat. J Neurosci Methods (2006) 0.91
Autoantibodies in complex regional pain syndrome bind to a differentiation-dependent neuronal surface autoantigen. Pain (2009) 0.91
Altered resting-state functional connectivity in complex regional pain syndrome. J Pain (2013) 0.91
Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives. Lancet Neurol (2009) 0.91
Frequency analysis unveils cardiac autonomic dysfunction after mild traumatic brain injury. J Neurotrauma (2011) 0.90
Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults. J Neurol (2012) 0.90